Latest News

Dr Reddy receives EIR for UK facility

Dr Reddy’s Laboratories has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration, for API Mirfield Plant, United Kingdom.

In September 2017, the US FDA had completed its audit of the plant and issued a Form 483 with three observations. It is has now received the EIR, indicating that the audit has been closed for the plant.

Read EquityPandit’s Technical Analysis of Dr Reddy

Click here to check market prediction for next trading session.

Get Daily Prediction & Stocks Tips On Your Mobile


I would like to receive communication from EquityPandit via sms, email, whatsapp, Google RCS for offers, updates etc.



📰
News
📈
Prediction
📊
FII / DII
👔
Advisory
Get 1-2 Index Option Trades Daily